QURE 주가 차트
QURE 재무
Uniqure NV
$21.16
2.32%
$0.48
종가: May 05, 16:00:00 GMT-4
$20.76
-1.89%
$-0.39
애프터마켓: May 05, 20:00:00 GMT-4
뒤로
Uniqure NV (QURE) 재무
주요 통계
이전 종가
$20.68
시가
$20.11
일일 범위
$19.76 - $21.27
52주 범위
$8.73 - $71.5
거래량
1.5M
평균 거래량
2.9M
배당수익률
--
EPS(TTM)
-3.48
시가총액
$1.2B
QURE란 무엇인가요?
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. The company is headquartered in Amsterdam, Noord-Holland and currently employs 221 full-time employees. The company went IPO on 2014-02-05. The company seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. The company develops, both internally and through partnerships, a pipeline of gene therapies. The company produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
